UnitedHealth Eliminates AbbVie's Humira from Formularies
UnitedHealth's Major Decision on Humira
In a pivotal change, UnitedHealth has announced the removal of AbbVie's Humira from its formularies, following similar actions from Cigna and CVS. This decision could affect countless patients who depend on this blockbuster therapy for inflammatory conditions.
Potential Effects on Patients
The exclusion of Humira from formularies may lead to challenges for patients in managing their health. Many will have to seek alternatives or engage in discussions with their healthcare providers.
Healthcare Implications
- This shift highlights ongoing changes in pharmaceutical policies.
- Patients may need to navigate new pathways to obtain similar medications.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.